EMEA Thought Leadership
EMEA Thought Leadership
Developing IQVIA’s positions on key trends. The Thought Leadership group regularly produces white papers, presentations and webinars, and is available to comment on a range of topics from launch excellence to global health.
Latest thinking
From Innovation to Integration: The Route Towards Realising the Potential of Wearable Technology to Prevent Cardiovascular Disease
White Paper
The obesity-inflammation axis: An emerging target for therapeutic innovation
Blog
By: Markus Gores
Key Takeaways from ECO 2026
Blog
By: Olivia Meadowcroft
Respiratory reimagined with targeted immunotherapies
Blog
By: Markus Gores
The EU Biotech Act (Part 1): A summary and review of its incentives
Blog
By: Philip Hines, Rachel Bailey, Marco Travaglio, Mariana Matos Rodrigues
Clinical Decision-Making in the Era of Generative AI
White Paper
The promise of advanced therapy combinations in immunology
Blog
By: Markus Gores, Dr. Stefan Lutzmayer
Longevity unlocked: From lifespan to healthspan extension
Blog
By: Dr. Stefan Lutzmayer, Caroline Celine Norbert
The outlook for obesity from 2026 to 2030
Blog
By: Olivia Meadowcroft, Sarah Rickwood, Luke Greenwalt
Seizing the Moment: Biotech’s Golden Opportunity for Self-Commercialisation
White Paper
The evolution of pharma engagement as AI becomes a front door to medical information
Blog
By: Kirstie Scott, Cristina Alzaga-Chaudhry
The Next Frontier of RNA Therapeutics
Blog
By: Dr. Stefan Lutzmayer, Toby House
Our webinars
Oncology Innovation: 2026 and Beyond
Webinar
June 23, 2026
The outlook for obesity from 2026 to 2030: From consolidation to acceleration
Webinar
March 18, 2026
Nine for 2026: Nine issues and trends that will shape the global healthcare and pharmaceutical environments for 2026 and beyond
Webinar
December 3, 2025
Immunology at an inflection point: Opportunities & challenges for innovators seeking growth in an unforgiving market
Webinar
October 1, 2025
Launch Excellence IX: Embracing change and unlocking efficiency
Webinar
July 3, 2025
Obesity in 2025 and beyond
Webinar
March 26, 2025
Executive summaries
A downloadable summary of all the white papers EMEA Thought Leadership has produced across all our areas of interest.
Our insights
Go-to-Market
Ensuring a successful launch is perhaps the most important stage of a product’s lifecycle. Explore the pitfalls and opportunities to look out for when launching a product, alongside how the environment is changing.
AI & Technology
Harnessing AI and technology is becoming essential to building the connected, agile, and insight-driven capabilities the life sciences industry needs for the future. Discover how smarter use of technology can improve efficiency, strengthen decision-making, and unlock benefits across healthcare.
Real world evidence, market access and medical
The collection of real world evidence and the involvement of medical affairs in customer engagement are becoming must-haves. Learn how these new tools can help your organisation to thrive.
Therapeutic innovation
The health and life sciences industries are highly innovative, with new treatment-defining developments a regular occurrence. Keep up-to-date with the latest therapeutic innovations.
Healthcare policy
Navigating a myriad of national and international government policy is a necessity for any organisation. Thought Leadership examines how to manage and leverage various policies and strategies.
Health systems
As the frontline services providing healthcare, ensuring successful operation of health systems is vital for all stakeholders. Discover how health systems can maximise patient benefits.
Global Public Health
In an increasingly connected world and with UN Sustainable Development Goal 3 aimed at improving health outcomes, learn about the benefits of focusing on health outside the major markets.
Knowledge hub Tackling Obesity Insights on a pervasive global health challenge. This knowledge hub combines key trends, research strategies and thought leadership, as well as providing solutions ranging from clinical research, real world data, market access and healthcare system capacity development, commercialisation and monitoring.